Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma

Objective: Evaluate the safety of albuterol multidose dry powder inhaler (MDPI), a novel, inhalation-driven device that does not require coordination of actuation with inhalation, in patients with persistent asthma. Methods: We report pooled safety data from two 12-week, multicenter, randomized, dou...

Descripción completa

Detalles Bibliográficos
Autores principales: Raphael, Gordon, Taveras, Herminia, Iverson, Harald, O’Brien, Christopher, Miller, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Pharmacotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819808/
https://www.ncbi.nlm.nih.gov/pubmed/26369589
http://dx.doi.org/10.3109/02770903.2015.1070862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819808/
https://www.ncbi.nlm.nih.gov/pubmed/26369589
http://dx.doi.org/10.3109/02770903.2015.1070862

Ejemplares similares